Skip to main content

Table 7 Benefit/risk ratio for LAI FGA and LAI SGA in schizophrenia

From: Guidelines for the use and management of long-acting injectable antipsychotics in serious mental illness

 

Prevention of psychotic recurrence

1 st line treatment

Risperidone LAI

2 nd line treatment

Olanzapine pamoate

Haloperidol decanoate

Zuclopenthixol decanoate

Flupentixol decanoate

Fluphenazine decanoate

Pipotiazine palmitate